Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats
Transboundary and Emerging Diseases · 2026
DOI: 10.1155/tbed/9499266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2026. Verfasst von Meng-Di Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, Guangdon…. Hauptthemen laut MEDLINE: Calicivirus, Feline, Caliciviridae Infections, Cat Diseases, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Feline calicivirus (FCV) is a major pathogen of upper respiratory tract diseases in cats, posing a significant threat to feline health. While current FCV preventive measures rely primarily on traditional vaccines, messenger RNA (mRNA) vaccines have emerged as a promising alternative, offering high efficacy, safety, rapid clinical development, and potential for fast, cost‐efficient production. In this study, we designed a modified nucleotide sequence with a 124‐amino acid deletion at a position in the region of the FCV‐VP1 protein as an immunogen. The plasmid encoding the codon‐optimized VP1 sequence was constructed, and VP1‐mRNA was generated by in vitro transcription (IVT) and capping. After transfection into BHK‐21 cells, immunofluorescence assay (IFA) and WB confirmed successful FCV‐VP1 expression. Subsequently, the mRNA was encapsulated into lipid nanoparticles (LNPs) to prepare the LNP‐VP1‐mRNA vaccine. Characterization analysis revealed a uniform particle size distribution (polydispersity index [PDI] = 0.169) and a stable surface charge (zeta potential = −1.67 mV). A prime‐boost immunization strategy was employed, which involved two intramuscular injections to immunize BALB/c mice or cats with the LNP‐VP1‐mRNA vaccine. ELISA analysis demonstrated that the vaccine elicited elevated levels of anti‐FCV IgG and neutralizing antibodies in a dose‐dependent manner, accompanied by the secretion of cytokines including IFN‐β, IFN‐γ, IL‐4, and IL‐6. Importantly, the VP1 mRNA vaccine provided complete protection against FCV challenge in cats, without the typical clinical signs and with a 100% survival rate. Our results indicate that the LNP‐VP1‐mRNA vaccine is a promising candidate for combating FCV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, Guangdong, China, scau.edu.cn.
- Xianghu Laboratory, Hangzhou, 311231, Zhejiang, China.
- College of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China, zcmu.edu.cn.
- Zhejiang Key Laboratory of Smart Biomaterials, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, Zhejiang, China, zju.edu.cn.
- Department of Veterinary Medicine, Zhejiang University, Hangzhou, 310058, Zhejiang, China, zju.edu.cn.
- State Key Laboratory of Animal Disease Control and Prevention, South China Agricultural University, Guangzhou, 510642, Guangdong, China, scau.edu.cn.
ORCID-Profile: Qian-Yu Qian, Jian-Bin Tang, Yao-Wei Huang, Yong-Le Yang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M. D., Xie, Z. F., Li, X. H., Huang, W., Qian, Q. Y., Cao, H. T., Liu, J. W., Zhang, Y. Q., Wang, B., Qin, Y., Shi, F. S., Tang, J. B., Huang, Y. W., & Yang, Y. L. (2026). Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats. Transboundary and Emerging Diseases. https://doi.org/10.1155/tbed/9499266
Vancouver
Zhang MD, Xie ZF, Li XH, Huang W, Qian QY, Cao HT, et al. Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats. Transboundary and Emerging Diseases. 2026. doi:10.1155/tbed/9499266
BibTeX
@article{Zhang2026,
author = {Zhang, Meng-Di and Xie, Zhuo-Fang and Li, Xin-Hong and Huang, Wei and Qian, Qian-Yu and Cao, Hong-Tao and Liu, Ji-Wei and Zhang, Ya-Qing and Wang, Bin and Qin, Yu and Shi, Fu-Shan and Tang, Jian-Bin and Huang, Yao-Wei and Yang, Yong-Le},
title = {Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in Cats},
journal = {Transboundary and Emerging Diseases},
year = {2026},
doi = {10.1155/tbed/9499266}
}
EUVIMED